1 |
Brennan M, Houssami N. Newly diagnosed early breast cancer-an update on pre-operative assessment and staging[J]. Aust Fam Physician, 2012, 41(11): 871-874.
|
2 |
Malmgren JA, Parikh J, Atwood MK, et al. Impact of mammography detection on the course of breast cancer in women aged 40-49 years[J]. Radiology, 2012, 262(3): 797-806.
|
3 |
van Steenbergen LN, Voogd AC, Roukema JA, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast[J]. Breast Cancer Res Treat, 2009, 115(1): 181-183.
|
4 |
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med, 2002, 347(16): 1227-1232.
|
5 |
Yu KD, Di GH, Wu J, et al. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data[J]. Ann Surg Oncol, 2007, 14(9): 2502-2509.
|
6 |
Hadi N, Soltanipour S, Talei A. Impact of modified radical mastectomy on health-related quality of life in women with early stage breast cancer[J]. Arch Iran Med, 2012, 15(8): 504-507.
|
7 |
Hunt KK, Meric-Bernstam F. Surgical options for breast cancer[M]. Chapter 7. 198-232.
|
8 |
Kelemen JJ 3rd, Poulton T, Swartz MT, et al. Surgical treatment of early-stage breast cancer in the Department of Defense Healthcare System[J]. J Am Coll Surg, 2001, 192(3): 293-297.
|
9 |
Lambert PA, Kolm P, Perry RR. Parameters that predict nipple involvement in breast cancer[J]. J Am Coll Surg, 2000, 191(4): 354-359.
|
10 |
Litière S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial[J]. Lancet Oncol, 2012, 13(4): 412-419.
|
11 |
Horiguchi J, Iino Y, Koibuchi Y, et al. Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan[J]. Breast Cancer, 2002, 9(2): 160-165.
|
12 |
Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial[J]. Cancer, 2003, 98(4): 697-702.
|
13 |
王圣应,朱正志,彭德峰, 等. 保留乳头乳晕复合体的改良根治术治疗早期乳腺癌患者疗效分析[J]. 癌症, 2009, 28(4): 408-411.
|
14 |
赵华锋. 保留乳头乳晕复合体的改良根治术在早期乳腺癌患者中的应用研究[J].中国医疗前沿, 2010, 5(22): 53, 63.
|
15 |
孟祥朝,陈玉琢,张自立, 等. 早期乳腺癌改良根治术中保留乳头乳晕25例报告[J]. 天津医科大学学报, 2010, 16(4): 672-673.
|
16 |
黄胜,陈德滇,周绍强, 等. 早期乳腺癌保留乳头乳晕的皮下乳腺癌改良根治术38例分析[J]. 昆明医学院学报, 2010, 31(10): 105-108.
|
17 |
李振. 28例早期乳腺癌保留乳头乳晕改良根治术的应用[J]. 贵阳中医学院学报, 2012, 34(3): 75-76.
|
18 |
Morrow M, Scott SK, Menck HR, et al. Factors influencing the use of breast reconstruction postmastectomy: a National Cancer Database study[J]. J Am Coll Surg, 2001, 192(1): 1-8.
|
19 |
Strozzo MD. An overview of surgical management of stage I and stage II breast cancer for the primary care provider[J]. Lippincotts Prim Care Pract, 1998, 2(2): 160-169.
|
20 |
Lee KT, Mun GH, Lim SY, et al. The impact of immediate breast reconstruction on post-mastectomy lymphedema in patients undergoing modified radical mastectomy[J]. Breast, 2012, 22(1): 53-57.
|
21 |
张斌明,杜延泽,杨碎胜, 等. 早期乳腺癌(I、IIa期)保留乳头乳晕复合体的改良根治术同期腹直肌肌皮瓣转移乳房再造15例报告[J]. 卫生职业教育, 2008, 26(4): 149-150.
|
22 |
张斌明,杨碎胜,杜延泽, 等. 保留乳头乳晕改良根治术同期TRAM瓣乳房重建治疗早期乳腺癌的临床研究[J]. 中华肿瘤防治杂志, 2009, 16(21): 1676-1679.
|
23 |
王圣应,鲁智,程新德, 等. 早期乳腺癌保留乳头乳晕复合体的改良根治术——Ⅰ期腹直肌肌皮瓣重建乳房[J]. 癌症, 2004, 23(1): 56-59.
|
24 |
孙永强,杨雯雯,梁文军, 等. 保留乳头乳晕的乳腺癌改良根治术后Ⅰ期假体植入乳房重建20例[J]. 医药论坛杂志, 2011, 32(22): 70-72.
|
25 |
高德宗,张强,李亮, 等.Ⅰ期假体植入乳房再造在保留乳头乳腺癌改良根治术中的临床应用[J]. 山东大学学报(医学版), 2010, 55(4): 106-108, 112.
|
26 |
王永成. 早期乳腺癌术后Ⅰ期假体植入乳房再造的应用[J]. 宁夏医学杂志, 2011, 33(5): 441-442.
|
27 |
Jobsen JJ, van der Palen J, Brinkhuis M, et al. Sequence of radiation therapy and chemotherapy as adjuvant treatment in breast cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 82(5): e811-817.
|
28 |
Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients[J]. J Natl Cancer Inst, 2010, 102(6): 401-409.
|
29 |
Mccoy JL, Rucker R, Petros JA. Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status[J]. Breast Cancer Res Treat, 2000, 60(3): 227-234.
|
30 |
魏景燕. 乳腺癌术后两种引流方法的效果比较[J].全科护理,2011, 9(11A): 2871
|
31 |
Vilar-Compte D, Jacquemin B, Robles-Vidal C, et al. Surgical site infections in breast surgery: case-control study[J]. World J Surg, 2004, 28(3): 242-246.
|
32 |
Mathes SJ, Alexander J. Radiation injury[J]. Surg Oncol Clin N Am, 1996, 5(4): 809-824.
|
33 |
Broadwater JR, Edwards MJ, Kuglen C, et al. Mastectomy following preoperative chemotherapy: strict operative criteria control operative morbidity[J]. Ann Surg, 1991, 213(2): 126-129.
|
34 |
Lim W, Park EH, Choi SL, et al. Breast conserving surgery for multifocal breast cancer[J]. Ann Surg, 2009, 249(1): 87-90.
|
35 |
Komoike Y, Akiyama F, Iino Y, et al. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases[J]. Cancer, 2006, 106(1): 35-41.
|
36 |
Jobsen JJ, Palen van der J, Meerwaldt JH. The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy[J]. Eur J Cancer, 2001, 37(15): 1820-1827.
|
37 |
杨名添,戎铁华,黄植蕃, 等. 可手术乳腺癌6263例临床分析[J]. 癌症, 2005, 24(3): 327-331.
|
38 |
张天泽,徐光炜. 肿瘤学(中册)[M]. 天津: 天津科学技术出版社, 1996: 1410.
|
39 |
Brachtel EF, Rusby JE, Michaelson JS, et al. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens[J]. J Clin Oncol, 2009, 27 (30): 4948-4954.
|
40 |
Gulben K, Yildirim E, Berberoglu U. Prediction of occult nippleareola complex involvement in breast cancer patients[J]. Neoplasma, 2009, 56(1): 72-75.
|
41 |
Banerjee A, Gupta S, Bhattacharya N. Preservation of nippleareola complex in breast cancer-a clinicopathological assessment[J]. J Plast Reconstr Aesthet Surg, 2008, 61(10): 1195-1198.
|
42 |
Kurian AW, Lichtensztajn DY, Keegan TH, et al. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007[J]. Breast Cancer Res Treat, 2012, 137(1): 247-260.
|
43 |
Faradmal J, Kazemnejad A, Khodabakhshi R, et al. Comparison of three adjuvant chemotherapy regimes using an extended log-logistic model in women with operable breast cancer[J]. Asian Pac J Cancer Prev, 2010, 11(2): 353-358.
|
44 |
Clarke M, Collins R, Darby S, et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and on 15-year survival: an overview of the randomised trials[J]. Lancet, 2005, 366(9503): 2087-2106.
|
45 |
Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial[J]. N Engl J Med, 1997, 337(14): 949-955.
|
46 |
Toi M, Benson JR, Winer EP, et al. Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference[J]. Breast Cancer Res Treat, 2012, 136(3): 919-926.
|
47 |
Leong LC, Gogna A, Pant R, et al. Supplementary breast ultrasound screening in Asian women with negative but dense mammograms-a pilot study[J]. Ann Acad Med Singapore, 2012, 41(10): 432-439.
|
48 |
Altinyollar H, Kapucuoglu N, Pak I, et al. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma[J]. J Exp Clin Cancer Res, 2000, 19(2): 141-144.
|
49 |
Palit TK, Miltenburg DM, Brunicardi FC. Cost analysis of breast conservation surgery compared with modified radical mastectomy with and without reconstruction[J]. Am J Surg, 2000, 179(6): 441-445.
|
50 |
Warren JL, Brown ML, Fay MP, et al. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings[J]. J Clin Oncol, 2002, 20(1): 307-316.
|
51 |
Barlow WE, Taplin SH, Yoshida CK, et al. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer[J]. J Natl Cancer Inst, 2001, 93(6): 447-455.
|
52 |
Parviz M, Cassel JB, Kaplan BJ, et al. Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer[J]. J Surg Oncol, 2003, 84(2): 57-62.
|